A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ₩271,507.35, with a 24-hour trading volume of ₩1.8B. The asset's market cap is ₩421.07T, after moving 0.31% in the last day.
Tokenized AstraZeneca PLC is trading at ₩157,584.89, with a tokenized market cap of ₩89.22B and a 24-hour trading volume of ₩1.19B. The tokenized asset has moved 2.13% in the past 24 hours.